Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. - Wikidata - awgldk - TriplyDB

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

http://www.wikidata.org/entity/Q36949233

about

Does PTH offer additive value to ALP measurement in assessing CKD-MBD?Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.Hyponatremia in patients with chronic kidney disease.Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012 Association of hemodialysis treatment time and dose with mortality and the role of race and sex.Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012.Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures.Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients.Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease.Increased serum alkaline phosphatase and serum phosphate as predictors of mortality after stroke.Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients Genome-wide association study on serum alkaline phosphatase levels in a Chinese population.Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study.A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: Need for new reference ranges.Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.Possible association between serum alkaline phosphatase concentration and thoracicacute aortic dissection.Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes.Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality Correlates of parathyroid hormone concentration in hemodialysis patients.Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients.Oxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis.A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population

P2860

Q26830747-1D002FCA-637F-48C8-84EC-FF879347BB0E Q26851216-8FFA499F-7599-4C7B-8B0F-09A92C1E6C21 Q30234466-5B755602-8177-47C4-BA11-13FE2ABE7548 Q30249295-FEA42436-6A85-4EEF-8BF9-09216A32790F Q30418571-584C913D-5FAB-43AF-ABD3-B336853977F4 Q30427552-01DDDE48-4BBF-4BF5-A5FE-2ACD44CB1F97 Q30429870-63CD0D08-7214-4995-9A9B-1F3B396774DC Q30430904-2230CCD8-9F5D-4975-9899-8F84143E9C07 Q30433029-5B01E84A-70B8-41A5-9894-830DCA9EC921 Q30976543-775E2D5F-F4B9-4544-B5B0-A6EF470545AC Q33578221-3321910A-2DBA-4B49-9A3D-40C7AA74BB68 Q33671574-02ED5BE4-6F72-4EDA-BDFB-94C8DDB29813 Q33862710-BFDC15BF-04BD-4DCC-A19C-3CA21C21C06B Q33878430-4D6A5E84-1F4D-43F4-94CA-60898BDA975C Q33888428-AD8F9AEA-6400-4EBE-9EF3-AD6B9CEE5A13 Q33932610-E9654B15-083B-4405-BBE4-E805735986B3 Q34135288-A5C3BF2E-595F-4358-B304-F4101BB19173 Q34140886-12EA7648-DFD7-435D-8276-E3A92991B639 Q34310554-4069E1C2-168A-4F82-9136-81B9D6DA0A5D Q34725113-E7517861-C854-420A-A723-F409A576333E Q34850611-CE9DB213-0DA9-42E1-A627-255CA65C6CBD Q35008233-C603A344-B915-46BE-B71A-D9E9BE4148B5 Q35013412-A8E0D0F7-E3FF-422F-8C8F-A8B0503C2063 Q35052500-7F376468-7032-4555-B990-67A9A8B641F0 Q35219236-87E84381-C07E-4E77-B40D-075A636F45C6 Q35229831-FD7A5F79-3FA0-48ED-B7DD-47D5B12296E2 Q35920190-9DC3114D-47E8-443F-91D3-0F51F801EA1D Q35961696-EF4F8DEF-F802-4BB5-84FB-64980E114B26 Q36035872-9ABB8151-E322-4F5C-850D-BFB16FC9F033 Q36054302-8CBD4C3F-31C8-4531-A29E-603FF7A0DB4B Q36193436-D35ED6F0-02C2-4B0E-8A33-89086B173627 Q36275393-518FEB0A-3880-45B8-93E4-65EBF6333407 Q36318181-3B10ACC0-EFDE-4572-B416-85C705873A2B Q36371052-024D5665-5199-4FE0-B82B-5FC70248BC72 Q36492567-0D4EA1B0-2FF6-430A-A375-F89AC5DBF734 Q36936601-11BD02DC-C50F-4308-99AA-971F62889F7C Q37123151-833F14AF-D083-4CD3-8BD9-84008583E0D2 Q37156964-4EDF5A78-AC9A-4CAF-AE6A-E11CCD675DFE Q37162734-C69745D8-D3F5-4ED3-9D7D-BAC5024B2F19 Q37198454-0BAE2FFA-3D3B-4BED-8890-7D74EDA80540

P2860

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

http://www.wikidata.org/entity/Q36949233

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

@en

type

label

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

@en

prefLabel

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

@en

P1433

Q36949233-D0A89DD2-4C0E-405B-A7DF-2D5E1607455A

P1476

Q36949233-22D77D47-963D-42A0-862B-9A295FB76700

P2093

Q36949233-4C00D531-0DB4-4B17-AEA6-2480F98BABCC

Q36949233-50506FDD-3B3E-4C2C-B313-6514AD68D5A4

Q36949233-7B723B6E-88C4-492C-91A8-142A1931D6E0

Q36949233-BA772933-4CB1-4AB5-8363-2C56F19691AB

Q36949233-E49FDC5C-A9FC-489E-A90C-DA512D30E514

P2860

Q36949233-099B3966-DCFF-4103-BA2F-AC34B54E8FAA

Q36949233-0B31A44E-9017-4D0B-851E-B0649E8BD84E

Q36949233-0D6CF044-E81E-40D2-BDBF-C1EAAEDB8E1B

Q36949233-0DE16D2F-9D98-4C5C-9AB5-B316CB553E28

Q36949233-0F950685-30E4-4980-A351-E9386C8D6C04

Q36949233-1450F55E-4F9F-4EC5-8291-A2D91522469C

Q36949233-198CF90B-5DD4-4121-9371-6C47C3279148

Q36949233-1EBEB11C-2EA2-4869-AACB-BFEE2773882D

Q36949233-21C58FFD-A944-4C17-937E-847FAA12A1B7

Q36949233-23ADC0F7-8D76-4B12-8497-CE0F60040401

P304

Q36949233-2DBE820F-B5E3-4AE3-B2A6-F6ACF9E2D4B3

P31

Q36949233-D8810895-41E6-4283-95DB-382AE9CDD7F8

P356

Q36949233-DCD53065-ACDC-4219-A057-815B807F80DB

P433

Q36949233-66621EB2-F7D6-419F-BC0F-2ABD6ECDAD39

P478

Q36949233-E05D4679-1CA6-4B4E-A401-900C49D00059

P50

Q36949233-3DB931E9-DB3C-47C6-856E-3AF98E8582F1

Q36949233-6FE2576B-CC48-4BD9-8966-6BD5B4759DDE

Q36949233-B207AC38-84BE-4E75-A21A-64DF9D5F26E0

Q36949233-DA52145E-C445-471E-B359-8358E8A1C33C

P577

Q36949233-CC4BF5DA-4C53-4CCF-B8AE-86D572605DDF

P5875

Q36949233-0B6A88F4-C6F7-48BA-95AB-F13F1C7D6F21

P698

Q36949233-A9404AD2-8D4D-48AD-81E1-4E25BC9B87E6

P932

Q36949233-1348F596-8E6F-4D8C-B998-F895FC0403C6

P356

P1433

Journal of the American Society of Nephrology

P1476

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

@en

P2093

Charles J McAllister

http://www.w3.org/2001/XMLSchema#string

David Van Wyck

http://www.w3.org/2001/XMLSchema#string

Deborah L Regidor

http://www.w3.org/2001/XMLSchema#string

Jennie Jing

http://www.w3.org/2001/XMLSchema#string

Mehdi Rambod

http://www.w3.org/2001/XMLSchema#string

P2860

The environment and disease: association or causation? 1965.

Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification

Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification.

Clinical inquiries. What is the differential diagnosis of an elevated alkaline phosphatase (AP) level in an otherwise asymptomatic patient?

Renal osteodystrophy, phosphate homeostasis, and vascular calcification.

Vascular calcification in dialysis patients: pathogenesis and consequences.

Why do dialysis patients develop a heart of stone and bone of china?

Impact of kidney bone disease and its management on survival of patients on dialysis.

Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Renal calcium stones: insights from the control of bone mineralization.

P304

2193-2203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2008010014

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Rajnish Mehrotra

Csaba P. Kovesdy

Kamyar Kalantar-Zadeh

P577

2008-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23138134

http://www.w3.org/2001/XMLSchema#string

P698

18667733

http://www.w3.org/2001/XMLSchema#string

P932

2573010

http://www.w3.org/2001/XMLSchema#string